- Researchers at the University of Sussex Innovation Center have produced a white paper linking patient empowerment, streamlined recruitment processes, and reduced workload for researchers with more effective clinical trial recruitment and execution.
- The research includes input from researchers, pharma, CROs, and patient advocacy groups.
- The white paper also suggests that the healthcare industry could improve outcomes by adopting a more secure central resource-collating, patient-data system.
The ongoing challenge of patient recruitment for clinical trials has become a major problem for pharma companies, because not having enough qualified patients for trials slows down the R&D process, costs money, wastes time, and makes it difficult to bring new drugs to market in a timely manner.
Researchers have proposed many solutions; but having empowered clinical trial participants is an integral part of solving the issue at hand. In fact, as BioPharma Dive has previously reported, patient groups that are able to more effectively leverage their resources through central organization are more likely to successfully access therapies, in part by influencing the clinical trial process.